【RNA藥物】《ReNAgade》完成3億美元A輪，由MPM BioImpact和F2 Ventures領投

 【RNA藥物】《ReNAgade》完成3億美元A輪融資，由MPM BioImpact和F2 Ventures領投

▌文章出處

 ReNAgade

▌原文標題

 ReNAgade Therapeutics Launches with Over $300 Million in Series A Financing to Unlock the Limitless Potential of RNA Medicine

▌Twitter

 https://twitter.com/aimedadviser/status/1661182484904542214

▌文章序號

 3572

 

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.